|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
![]() ![]() Media Home | Contact Us |
![]() |
![]() |
|
![]() |
The MMWR is embargoed until 12 Noon, ET, Thursdays.
Note: There is no telebriefing scheduled for July 18, 2002. Synopsis for July 19, 2002Tetanus ― Puerto Rico, 2002Tetanus vaccine is inexpensive, safe, and effective.
Between February and May 2002, the Puerto Rico Department of Health (PRDOH) received reports of three tetanus cases, two of which were fatal. None of the three persons had a definite history of prior vaccination with tetanus toxoid and none was younger than 60 years of age. This is consistent with the experience of the United States as a whole where tetanus is associated with lack of vaccination or incomplete vaccination, and more frequently occurs in older age groups. The increased risk in older persons is thought due to the greater likelihood that they never received a primary vaccination series or might not have received subsequent tetanus boosters. Now that the tetanus vaccine shortage has ended, health-care providers should review the vaccination status of all patients and administer tetanus vaccine (Td) as indicated. Pertussis Deaths ― United States, 2000Medical care providers should consider pertussis as a cause of new cough illness in persons of all ages.
In 2000, 17 pertussis (i.e., whooping cough) deaths were reported in the United States. All deaths occurred in U.S.-born infants who became sick before 4 months of age. Infants vulnerable to Bordetella pertussis infection are those aged <6 months or those who have not yet received 3 doses of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine. B. pertussis can be transmitted to vulnerable infants by infected parents, siblings, and others. To help prevent additional cases of pertussis, antibiotics can be used to treat persons with pertussis and their close contacts, including exposed infants. Timely vaccination of infants and children according to current recommendations remains the most effective way for parents and health-care providers to prevent pertussis. Infants should receive the first DTaP vaccine at age 2 months, followed by doses at ages 4, 6, and 1518 months, and a booster dose at age 46 years. Hepatitis B Vaccination Among High-Risk Adolescents and Adults ― San Diego, California 19982001San Diego County has implemented a community-wide hepatitis B vaccination program for high-risk adolescents and adults.
The program has been integrated into existing programs that serve high risk persons, such as clinics for the treatment of sexually transmitted diseases. Approximately 1.2 million persons in the United States have chronic HBV infection, and an estimated 4,000 5,000 persons die each year from HBV-related liver diseases. Despite the availability of a safe and effective vaccine that has been recommended for persons at high risk of infection with hepatitis B virus (HBV) infection for more than 20 years, adults and older adolescents with high-risk sex and drug behaviors are still not getting routinely vaccinated.
|
![]() |
![]() |
CDC Home | Search | Health Topics A-Z This page last reviewed July 18, 2002 Centers
for Disease Control and Prevention |